Rony Schaffel
Rio De Janeiro, RJ, Brazil
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Comparison of Carmustine-, Lomustine-, and Nitrosourea-Free Conditioning Regimens for Autologous HCT (Auto-HCT) in Lymphoma: Results From the Hematopoietic Cell Transplantation Brazilian Registry (HCTBR).
Journal: Transplantation and cellular therapy
Published: March 23, 2026
Regional Disparities and Socioeconomic Factors Affecting Outcomes of Hematopoietic Cell Transplantation in Brazil: Insights From the Brazilian Bone Marrow Transplant Map.
Journal: Transplantation and cellular therapy
Published: October 25, 2025
The potential role of biosimilars in healthcare sustainability in Latin America.
Journal: Expert opinion on biological therapy
Published: May 15, 2025
Prevalence and survival outcomes of adult T-cell leukemia/lymphoma in Latin America: A multicenter cohort study and recommendations to improve diagnosis and outcomes.
Journal: Cancer epidemiology
Published: May 13, 2025
Diagnosis and treatment of chronic lymphocytic leukemia: 2025 recommendations of the Brazilian Group of Chronic Lymphocytic Leukemia of the Brazilian Association of Hematology and Hemotherapy (ABHH).
Journal: Hematology, transfusion and cell therapy
Published: March 21, 2025
Mantle Cell Lymphoma Under the Scope of Personalized Medicine: Perspective and Directions.
Journal: Clinical lymphoma, myeloma & leukemia
Published: February 27, 2024
Application of EBMT, MASCC, and qSOFA Scores to Predict Complicated Febrile Neutropenia and Mortality in Autologous Stem Cell Transplant Recipients.
Journal: Hematology/oncology and stem cell therapy
Published: February 15, 2022
How to manage lymphoid malignancies during novel 2019 coronavirus (CoVid-19) outbreak: a Brazilian task force recommendation.
Journal: Hematology, transfusion and cell therapy
Published: March 27, 2020
Induction therapy and stem-cell mobilization in myeloma, look at the past to plan the future.
Journal: Hematology, transfusion and cell therapy
Published: September 17, 2019
Early molecular response ≤1% has strong prognostic impact for CML patients that switch to second-line therapy with BCR-ABL1 ≤10% and no major molecular response.
Journal: British journal of haematology
Published: October 20, 2018
Erratum to "Diagnosis and treatment of chronic lymphocytic leukemia: Recommendations from the Brazilian Group of Chronic Lymphocytic Leukemia" [Rev Bras Hematol Hemoter. 2016;38(4):346-357].
Journal: Revista brasileira de hematologia e hemoterapia
Published: March 09, 2017
Diagnosis and treatment of chronic lymphocytic leukemia: recommendations from the Brazilian Group of Chronic Lymphocytic Leukemia.
Journal: Revista brasileira de hematologia e hemoterapia
Published: July 19, 2016
Last Updated: 09/26/2026